Cargando…

Dendritic Cell Plasticity in Tumor-Conditioned Skin: CD14(+) Cells at the Cross-Roads of Immune Activation and Suppression

Tumors abuse myeloid plasticity to re-direct dendritic cell (DC) differentiation from T cell stimulatory subsets to immune-suppressive subsets that can interfere with anti-tumor immunity. Lined by a dense network of easily accessible DC the skin is a preferred site for the delivery of DC-targeted va...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Ven, Rieneke, Lindenberg, Jelle J., Oosterhoff, Dinja, de Gruijl, Tanja D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839226/ https://www.ncbi.nlm.nih.gov/pubmed/24324467 http://dx.doi.org/10.3389/fimmu.2013.00403

Ejemplares similares

Functional characterization of a STAT3-dependent dendritic cell-derived CD14(+) cell population arising upon IL-10-driven maturation
por: Lindenberg, Jelle J., et al.
Publicado: (2013)

Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition
por: Oosterhoff, Dinja, et al.
Publicado: (2012)

IL-10 Conditioning of Human Skin Affects the Distribution of Migratory Dendritic Cell Subsets and Functional T Cell Differentiation
por: Lindenberg, Jelle J., et al.
Publicado: (2013)

Comparative phenotypic and functional analysis of migratory dendritic cell subsets from human oral mucosa and skin
por: Kosten, Ilona Jennifer, et al.
Publicado: (2017)

Constitutively active GSK3β as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppression
por: López González, Marta, et al.
Publicado: (2019)

Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines
por: van Dinther, Dieke, et al.
Publicado: (2017)

Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node
por: van Pul, Kim M., et al.
Publicado: (2019)

Hematopoietic Cancer Cell Lines Can Support Replication of Sabin Poliovirus Type 1
por: Oosterhoff, Dinja, et al.
Publicado: (2015)

Counteracting breast-cancer induced immune suppression by reactivating lymph node-resident conventional dendritic cells (LNR-cDC)
por: van de Ven, Rieneke, et al.
Publicado: (2015)

Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses
por: Stolk, Dorian A., et al.
Publicado: (2020)

High susceptibility of c-KIT(+)CD34(+) precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line model
por: van de Ven, Rieneke, et al.
Publicado: (2011)

Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy
por: van Pul, Kim M., et al.
Publicado: (2021)

Palmitoylated antigens for the induction of anti-tumor CD8(+) T cells and enhanced tumor recognition
por: Stolk, Dorian A., et al.
Publicado: (2021)

Transcriptional Profiling of Human Dendritic Cell Populations and Models - Unique Profiles of In Vitro Dendritic Cells and Implications on Functionality and Applicability
por: Lundberg, Kristina, et al.
Publicado: (2013)

Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway
por: van Pul, Kim M, et al.
Publicado: (2020)

Phenotypic and Functional Properties of Human Steady State CD14(+) and CD1a(+) Antigen Presenting Cells and Epidermal Langerhans Cells
por: Fehres, Cynthia. M., et al.
Publicado: (2015)

Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCs
por: Chondronasiou, Dafni, et al.
Publicado: (2018)

Evidence for a coordinate role of CD14+ antigen-presenting cells and regulatory T cells in conditioning the microenvironment of metastatic lymph nodes from patients with cervical cancer
por: Heeren, Marijne, et al.
Publicado: (2014)

Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy
por: Prokopi, Anastasia, et al.
Publicado: (2021)

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines
por: de Gruijl, Tanja D., et al.
Publicado: (2008)

Oncolytic adenovirus ORCA‐010 increases the type 1 T cell stimulatory capacity of melanoma‐conditioned dendritic cells
por: López González, M., et al.
Publicado: (2020)

CD169 Defines Activated CD14(+) Monocytes With Enhanced CD8(+) T Cell Activation Capacity
por: Affandi, Alsya J., et al.
Publicado: (2021)

Resident CD141 (BDCA3)(+) dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation
por: Chu, Chung-Ching, et al.
Publicado: (2012)

High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodes
por: van de Ven, Rieneke, et al.
Publicado: (2017)

Profiling of suppressive immune subsets in metastasis negative and positive sentinel lymph nodes from patients with HER2- breast cancer
por: van de Ven, Rieneke, et al.
Publicado: (2014)

Construction of a Vero Cell Line Expressing Human ICAM1 for the Development of Rhinovirus Vaccines
por: van den Braak, Wouter Johannes Petrus, et al.
Publicado: (2022)

Development of an Inflammatory CD14(+) Dendritic Cell Subset in Humanized Mice
por: Iwabuchi, Ryutaro, et al.
Publicado: (2021)

CD14 Expressing Precursors Give Rise to Highly Functional Conventional Dendritic Cells for Use as Dendritic Cell Vaccine
por: Plantinga, Maud, et al.
Publicado: (2021)

Dendritic Cells and T Cells, Partners in Atherogenesis and the Translating Road Ahead
por: Sun, Li, et al.
Publicado: (2020)

Pathogenesis of Skin Carcinomas and a Stem Cell as Focal Origin
por: de Gruijl, Frank R., et al.
Publicado: (2018)

A Human Cell Line Model for Interferon-α Driven Dendritic Cell Differentiation
por: Ruben, Jurjen M., et al.
Publicado: (2015)

Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
por: Datsi, Angeliki, et al.
Publicado: (2021)

Transfer of Cellular Content from the Allogeneic Cell-Based Cancer Vaccine DCP-001 to Host Dendritic Cells Hinges on Phosphatidylserine and Is Enhanced by CD47 Blockade
por: Zuo, Haoxiao, et al.
Publicado: (2021)

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)

Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen
por: Ruben, Jurjen M., et al.
Publicado: (2015)

Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy
por: Ghasemi, Matin, et al.
Publicado: (2023)

Socs1-knockout in skin-resident CD4(+) T cells in a protracted contact-allergic reaction results in an autonomous skin inflammation with features of early-stage mycosis fungoides
por: Luo, Yixin, et al.
Publicado: (2023)

Gingiva Equivalents Secrete Negligible Amounts of Key Chemokines Involved in Langerhans Cell Migration Compared to Skin Equivalents
por: Kosten, Ilona J., et al.
Publicado: (2015)

Single-cell analysis of human skin identifies CD14(+) type 3 dendritic cells co-producing IL1B and IL23A in psoriasis
por: Nakamizo, Satoshi, et al.
Publicado: (2021)

Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ppjpgcq4tr72ijj1rt8p13knic